{
 "drug": "Atropine Sulfate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "01/01/2012",
 "dayN": 5350,
 "cat": "Anesthesia",
 "companies": [
  "Medefil, Inc.",
  "Accord Healthcare Inc.",
  "Somerset Therapeutics, LLC",
  "Hospira, Inc., a Pfizer Company",
  "Amphastar Pharmaceuticals, Inc.",
  "American Regent, Inc.",
  "Hikma Pharmaceuticals USA, Inc.",
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [
  "Discontinuation of the manufacture of the drug",
  "Requirements related to complying with good manufacturing practices",
  "Other"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "64253-400-91",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "630-682-4600",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA214970"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE INJECTION"
    ],
    "manufacturer_name": [
     "Medefil, Inc."
    ],
    "product_ndc": [
     "64253-400"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546"
    ],
    "spl_id": [
     "46a6a31f-46ab-a437-e063-6394a90a4ad0"
    ],
    "spl_set_id": [
     "fbfdf718-befe-ad22-e053-6294a90a3715"
    ],
    "package_ndc": [
     "64253-400-30",
     "64253-400-91"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)",
   "company_name": "Medefil, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2020",
   "package_ndc": "16729-484-45",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA212868"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc.,"
    ],
    "product_ndc": [
     "16729-484",
     "16729-483"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546",
     "1190551",
     "1190552"
    ],
    "spl_id": [
     "4082a1cf-1e1b-6f40-e063-6294a90aec06"
    ],
    "spl_set_id": [
     "c82cb295-ffce-47d6-97ad-a8aa723f4e4f"
    ],
    "package_ndc": [
     "16729-483-03",
     "16729-483-31",
     "16729-484-90",
     "16729-484-31",
     "16729-484-45",
     "16729-484-03"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)",
   "company_name": "Accord Healthcare Inc.",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "70069-481-10",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215005"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE MONOHYDRATE"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-481"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ENDOTRACHEAL",
     "INTRAMEDULLARY",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190776"
    ],
    "spl_id": [
     "125328fe-c82b-42fd-bb3b-ba3f6c125ced"
    ],
    "spl_set_id": [
     "84ba1689-3030-48d5-9cce-70b5a24a4033"
    ],
    "package_ndc": [
     "70069-481-01",
     "70069-481-10"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0409-4911-34",
   "generic_name": "Atropine Sulfate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Atropine+Sulfate+Injection&st=d&tab=tabs-2",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)\"",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2020",
   "package_ndc": "76329-3340-1",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "800-423-4136",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA212461"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "International Medication Systems, Limited"
    ],
    "product_ndc": [
     "76329-3340"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546"
    ],
    "spl_id": [
     "697aa53c-f31f-463a-a752-d2faaad354db"
    ],
    "spl_set_id": [
     "b72d0a82-6163-460f-965a-12f6da47370a"
    ],
    "package_ndc": [
     "76329-3340-1"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)",
   "company_name": "Amphastar Pharmaceuticals, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2020",
   "package_ndc": "16729-483-03",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA212868"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc.,"
    ],
    "product_ndc": [
     "16729-483",
     "16729-484"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546",
     "1190551",
     "1190552"
    ],
    "spl_id": [
     "4082a1cf-1e1b-6f40-e063-6294a90aec06"
    ],
    "spl_set_id": [
     "c82cb295-ffce-47d6-97ad-a8aa723f4e4f"
    ],
    "package_ndc": [
     "16729-483-03",
     "16729-483-31",
     "16729-484-90",
     "16729-484-31",
     "16729-484-45",
     "16729-484-03"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0517-1001-25",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "800-645-1706",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216120"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "American Regent, Inc."
    ],
    "product_ndc": [
     "0517-1001",
     "0517-1004"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190795",
     "1666781"
    ],
    "spl_id": [
     "1c500ed9-94a9-472c-bfb7-50e1fcfc31fb"
    ],
    "spl_set_id": [
     "6fee1727-52b7-4f73-ab45-ef47d6a1c5bb"
    ],
    "package_ndc": [
     "0517-1004-01",
     "0517-1004-25",
     "0517-1001-01",
     "0517-1001-25"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)",
   "company_name": "American Regent, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0409-9630-05",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA021146"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-9630",
     "0409-1630",
     "0409-4910",
     "0409-4911"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546",
     "1190551",
     "1190552"
    ],
    "spl_id": [
     "3f33c683-46fb-40db-af0d-9211bc29d2a7"
    ],
    "spl_set_id": [
     "ad8916e7-206e-409e-2582-30d072845dd4"
    ],
    "package_ndc": [
     "0409-1630-15",
     "0409-1630-10",
     "0409-9630-15",
     "0409-9630-05",
     "0409-4910-11",
     "0409-4910-34",
     "0409-4911-11",
     "0409-4911-34"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "70069-631-25",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215969"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-631",
     "70069-641"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190795",
     "1666781"
    ],
    "spl_id": [
     "7a8a5552-fe21-4d36-8396-b7c99f41b4c4"
    ],
    "spl_set_id": [
     "a6fac578-c7bc-4b3c-a454-7889cc819118"
    ],
    "package_ndc": [
     "70069-631-01",
     "70069-631-25",
     "70069-641-01",
     "70069-641-25"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "12/20/2023",
   "package_ndc": "0641-6251-10",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "800-631-2174",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA213561"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0641-6251"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ENDOTRACHEAL",
     "INTRAMEDULLARY",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190776"
    ],
    "spl_id": [
     "f5ca4281-8c89-4efc-80b1-2fbcf61c7c55"
    ],
    "spl_set_id": [
     "4c15d3cc-7888-4c82-b3f8-a5d93c5523df"
    ],
    "package_ndc": [
     "0641-6251-10"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "16729-525-08",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "New",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "70069-641-25",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "732-554-1037",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA215969"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Somerset Therapeutics, LLC"
    ],
    "product_ndc": [
     "70069-641",
     "70069-631"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190795",
     "1666781"
    ],
    "spl_id": [
     "7a8a5552-fe21-4d36-8396-b7c99f41b4c4"
    ],
    "spl_set_id": [
     "a6fac578-c7bc-4b3c-a454-7889cc819118"
    ],
    "package_ndc": [
     "70069-631-01",
     "70069-631-25",
     "70069-641-01",
     "70069-641-25"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "07/20/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)",
   "company_name": "Somerset Therapeutics, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0409-1630-10",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Next Delivery: August 2026; Estimated Recovery: September 2026. Shortage per Manufacturer: Manufacturing Delay.",
   "openfda": {
    "application_number": [
     "NDA021146"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Hospira, Inc."
    ],
    "product_ndc": [
     "0409-1630",
     "0409-9630",
     "0409-4910",
     "0409-4911"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546",
     "1190551",
     "1190552"
    ],
    "spl_id": [
     "3f33c683-46fb-40db-af0d-9211bc29d2a7"
    ],
    "spl_set_id": [
     "ad8916e7-206e-409e-2582-30d072845dd4"
    ],
    "package_ndc": [
     "0409-1630-15",
     "0409-1630-10",
     "0409-9630-15",
     "0409-9630-05",
     "0409-4910-11",
     "0409-4910-34",
     "0409-4911-11",
     "0409-4911-34"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-4911-34",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2)  (NDC 0409-4911-34)\"",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0409-4910-34",
   "generic_name": "Atropine Sulfate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Atropine+Sulfate+Injection&st=d&tab=tabs-2",
   "contact_info": "844-646-4398",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)\"",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "0517-1004-25",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "800-645-1706",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA216120"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "American Regent, Inc."
    ],
    "product_ndc": [
     "0517-1004",
     "0517-1001"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190795",
     "1666781"
    ],
    "spl_id": [
     "1c500ed9-94a9-472c-bfb7-50e1fcfc31fb"
    ],
    "spl_set_id": [
     "6fee1727-52b7-4f73-ab45-ef47d6a1c5bb"
    ],
    "package_ndc": [
     "0517-1004-01",
     "0517-1004-25",
     "0517-1001-01",
     "0517-1001-25"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)",
   "company_name": "American Regent, Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "16729-512-43",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "openfda": {
    "application_number": [
     "ANDA213424"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Accord Healthcare Inc."
    ],
    "product_ndc": [
     "16729-512"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ENDOTRACHEAL",
     "INTRAMEDULLARY",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190776"
    ],
    "spl_id": [
     "275def6c-5b2d-918b-e063-6294a90aa71f"
    ],
    "spl_set_id": [
     "f3cb74e9-b4ac-4efe-bd8e-8a71970ee7c7"
    ],
    "package_ndc": [
     "16729-512-05",
     "16729-512-43"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "63323-580-20",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "888-386-1300",
   "availability": "Available",
   "related_info": "Check wholesalers for inventory",
   "openfda": {
    "application_number": [
     "NDA209260"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-580"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ENDOTRACHEAL",
     "INTRAMEDULLARY",
     "INTRAMUSCULAR",
     "INTRAVENOUS",
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190776"
    ],
    "spl_id": [
     "8039a2a4-4c0a-4062-9ca5-78137ba74082"
    ],
    "spl_set_id": [
     "310c8a74-ea24-4357-8099-81e394b1634e"
    ],
    "package_ndc": [
     "63323-580-20"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "Current"
  },
  {
   "discontinued_date": "11/07/2025",
   "update_type": "New",
   "initial_posting_date": "11/07/2025",
   "package_ndc": "0409-4910-34",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "update_date": "11/07/2025",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)\"",
   "company_name": "Hospira, Inc., a Pfizer Company",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2020",
   "package_ndc": "16729-484-90",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA212868"
    ],
    "brand_name": [
     "ATROPINE SULFATE"
    ],
    "generic_name": [
     "ATROPINE SULFATE"
    ],
    "manufacturer_name": [
     "Accord Healthcare, Inc.,"
    ],
    "product_ndc": [
     "16729-484",
     "16729-483"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "ATROPINE SULFATE"
    ],
    "rxcui": [
     "1190546",
     "1190551",
     "1190552"
    ],
    "spl_id": [
     "4082a1cf-1e1b-6f40-e063-6294a90aec06"
    ],
    "spl_set_id": [
     "c82cb295-ffce-47d6-97ad-a8aa723f4e4f"
    ],
    "package_ndc": [
     "16729-483-03",
     "16729-483-31",
     "16729-484-90",
     "16729-484-31",
     "16729-484-45",
     "16729-484-03"
    ],
    "unii": [
     "03J5ZE7KA5"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/01/2012",
   "package_ndc": "16729-526-08",
   "generic_name": "Atropine Sulfate Injection",
   "contact_info": "866-941-7875, option 2",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: TBD",
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anesthesia",
    "Neurology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)",
   "company_name": "Accord Healthcare Inc.",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  }
 ]
}